{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:14:32Z","timestamp":1776867272573,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20200201559JC"],"award-info":[{"award-number":["20200201559JC"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.yexmp.2021.104665","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:02:53Z","timestamp":1625097773000},"page":"104665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT\/mTOR pathway in bladder cancer"],"prefix":"10.1016","volume":"121","author":[{"given":"Xingzhe","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huazi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaogang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2021.104665_bb0005","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/s41467-019-10946-y","article-title":"Regulation of tumor angiogenesis and mesenchymal-endothelial transition by p38\u03b1 through TGF-\u03b2 and JNK signaling","volume":"10","author":"Batlle","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2021.104665_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2021.104665_bb0015","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-18-3842","article-title":"Acid-related orphan receptor C regulates proliferation, glycolysis, and Chemoresistance via the PD-L1\/ITGB6\/STAT3 signaling axis in Bladder Cancer","volume":"79","author":"Cao","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2021.104665_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/cells8080803","article-title":"Role and therapeutic targeting of the PI3K\/Akt\/mTOR signaling pathway in Skin Cancer: a review of current status and future trends on natural and synthetic agents therapy","volume":"8","author":"Chamcheu","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.yexmp.2021.104665_bb0025","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/hep.29663","article-title":"High mobility group protein B1 controls liver cancer initiation through yes-associated protein-dependent aerobic glycolysis","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.yexmp.2021.104665_bb0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13577-019-00237-5","article-title":"SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake","volume":"32","author":"Chen","year":"2019","journal-title":"Hum. Cell"},{"key":"10.1016\/j.yexmp.2021.104665_bb0035","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7150\/thno.30056","article-title":"Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer","volume":"9","author":"Deng","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.yexmp.2021.104665_bb0040","first-page":"258","article-title":"Role of angiogenesis in urothelial bladder carcinoma","volume":"69","author":"Fus","year":"2016","journal-title":"Cent. Eur. J. Urol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","article-title":"A lactate-induced response to hypoxia","volume":"161","author":"Lee","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.yexmp.2021.104665_bb0050","first-page":"311","article-title":"Suppression of HBXIP reduces cell proliferation, migration and invasion in vitro, and tumorigenesis in vivo in human Urothelial carcinoma of the bladder","volume":"31","author":"Li","year":"2016","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.yexmp.2021.104665_bb0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.canlet.2014.09.047","article-title":"The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2\/ERK1\/2\/Capn4 signaling","volume":"355","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2021.104665_bb0060","first-page":"1607","article-title":"Clinicopathological and prognostic significance of HBXIP overexpression in patients with bladder urothelial carcinoma","volume":"23","author":"Li","year":"2016","journal-title":"Chin. J. Cancer Prev. Treat."},{"key":"10.1016\/j.yexmp.2021.104665_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-020-1522-3","article-title":"KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation","volume":"39","author":"Li","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2021.104665_bb0070","doi-asserted-by":"crossref","first-page":"30228","DOI":"10.1074\/jbc.M112.343947","article-title":"The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexmp.2021.104665_bb0075","first-page":"192","article-title":"Latest research progress on the hepatitis B X-interacting protein (HBXIP)","volume":"31","author":"Liu","year":"2012","journal-title":"Genom. Appl. Biol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0080","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/carcin\/bgu021","article-title":"The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF","volume":"35","author":"Liu","year":"2014","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.yexmp.2021.104665_bb0085","doi-asserted-by":"crossref","first-page":"27199","DOI":"10.18632\/oncotarget.4508","article-title":"The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.yexmp.2021.104665_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-018-0577-5","article-title":"Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer","volume":"11","author":"Liu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0095","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41401-018-0015-9","article-title":"Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer","volume":"40","author":"Liu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexmp.2021.104665_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007484","article-title":"EBV-miR-BART1-5P activates AMPK\/mTOR\/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma","volume":"14","author":"Lyu","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexmp.2021.104665_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.hoc.2014.10.001","article-title":"Epidemiology of bladder cancer","volume":"29","author":"Malats","year":"2015","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.yexmp.2021.104665_bb0110","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/emboj\/cdg263","article-title":"HBXIP functions as a colactor of survivin in apoptosis suppression","volume":"22","author":"Marusawa","year":"2003","journal-title":"EMBO."},{"key":"10.1016\/j.yexmp.2021.104665_bb0115","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/jcp.26049","article-title":"Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis","volume":"233","author":"Mashreghi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.yexmp.2021.104665_bb0125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-05-1284","article-title":"Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-a, -C, and -D","volume":"12","author":"Miyata","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2021.104665_bb0130","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2147\/OTT.S243250","article-title":"HBXIP regulates gastric Cancer glucose metabolism and malignancy through PI3K\/AKT and p53 signaling","volume":"13","author":"Qiu","year":"2020","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.yexmp.2021.104665_bb0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","article-title":"Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis","volume":"73","author":"Roudnicky","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2021.104665_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmet.2013.11.008","article-title":"Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis","volume":"19","author":"Schoors","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.yexmp.2021.104665_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033418","article-title":"Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis","volume":"7","author":"Sonveaux","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2021.104665_bb0150","doi-asserted-by":"crossref","first-page":"4848752","DOI":"10.1155\/2020\/4848752","article-title":"The dependence between urinary levels of angiogenesis factors, 8-iso-prostaglandin F2\u03b1, \u0263-synuclein, and interleukin-13 in patients with Bladder Cancer: a pilot study","volume":"2020","author":"Szyma\u0144ska","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ebiom.2019.08.043","article-title":"Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis","volume":"47","author":"Wade","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.yexmp.2021.104665_bb0160","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/onc.2017.13","article-title":"Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1\u03b1","volume":"36","author":"Wan","year":"2017","journal-title":"Oncogene."},{"key":"10.1016\/j.yexmp.2021.104665_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11010-011-1215-5","article-title":"Overexpression of hepatitis B x-interacting protein in HepG2 cells enhances tumor-induced angiogenesis","volume":"364","author":"Wang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexmp.2021.104665_bb0170","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.canlet.2016.10.018","article-title":"The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer","volume":"385","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2021.104665_bb0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.30923","article-title":"CRAF methylation by PRMT6 regulates aerobic glycolysis-driven Hepatocarcinogenesis via ERK-dependent PKM2 nuclear Relocalization and activation","volume":"71","author":"Wong","year":"2020","journal-title":"Hepatology."},{"key":"10.1016\/j.yexmp.2021.104665_bb0180","doi-asserted-by":"crossref","first-page":"111045","DOI":"10.1016\/j.biopha.2020.111045","article-title":"The oncogenic role of HBXIP","volume":"133","author":"Xiu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2021.104665_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2013.01.029","article-title":"The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells","volume":"333","author":"Xu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2021.104665_bb0190","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/jcp.30128","article-title":"HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1\u03b1","volume":"236","author":"Yang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexmp.2021.104665_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1476-4598-13-128","article-title":"Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP","volume":"13","author":"Zhang","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexmp.2021.104665_bb0200","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/thno.28992","article-title":"LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR signaling pathway","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480021000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480021000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:00:30Z","timestamp":1762146030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480021000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"alternative-id":["S0014480021000642"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2021.104665","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT\/mTOR pathway in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2021.104665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104665"}}